Patents Assigned to Bluefin BioMedicine, Inc.
  • Anti-TMEFF1 antibodies and antibody drug conjugates
    Patent number: 11981732
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: March 14, 2022
    Date of Patent: May 14, 2024
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet
  • Anti-VTCN1 antibodies and antibody drug conjugates
    Patent number: 11932694
    Abstract: Disclosed herein are anti-V-set domain containing T cell activation inhibitor 1 (VTCN1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: March 19, 2024
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Ailan Guo, Svetlana Popova, Scott Michael Lonning, Jason G. Beaudet
  • Anti-cub domain-containing protein 1 (CDCP1) antibodies, antibody drug conjugates, and methods of use thereof
    Patent number: 11702481
    Abstract: This disclosure relates to anti-cancer antibodies and methods of treatment, detection, and diagnosis using the same.
    Type: Grant
    Filed: December 15, 2017
    Date of Patent: July 18, 2023
    Assignee: Bluefin Biomedicine, Inc.
    Inventors: Hong Ren, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Tinglei Gu
  • Anti-SEZ6L2 antibodies and antibody drug conjugates
    Patent number: 11634486
    Abstract: Disclosed herein are anti-Seizure Related 6 Homolog Like 2 (SEZ6L2) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: April 25, 2023
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Kevin Jefferies, Scott Michael Lonning, Nels Eric Pederson, Jason G. Beaudet, Klarisa Rikova, Aleksandr Tkachev
  • ANTI-VTCN1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20230069760
    Abstract: Disclosed herein are anti-V-set domain containing T cell activation inhibitor 1 (VTCN1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: April 19, 2018
    Publication date: March 2, 2023
    Applicants: Bluefin BioMedicine, Inc., Bluefin BioMedicine, Inc.
    Inventors: Ailan Guo, Svetlana Popova, Scott Michael Lonning, Jason G. Beaudet
  • Anti-LY6H antibodies and antibody drug conjugates
    Patent number: 11434303
    Abstract: Disclosed herein are anti-lymphocyte antigen 6 complex, locus H (LY6H) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: September 6, 2022
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Tinglei Gu, Scott Michael Lonning, Nels Eric Pederson, Aleksandr Tkachev, Klarisa Rikova, Sean A. Beausoleil
  • Anti-TMEFF1 antibodies and antibody drug conjugates
    Patent number: 11312769
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: April 26, 2022
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet
  • Anti-ILT3 antibodies and antibody drug conjugates
    Patent number: 11267886
    Abstract: Disclosed herein are anti-immunoglobulin-like transcript-3 (ILT3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: February 9, 2018
    Date of Patent: March 8, 2022
    Assignee: Bluefin BioMedicine, Inc.
    Inventors: Jaime Darce, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev
  • Anti-IL1RAP antibodies and antibody drug conjugates
    Patent number: 11248054
    Abstract: Disclosed herein are Interleukin 1 Receptor Accessory Protein (IL1RAP) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: February 15, 2022
    Assignee: BLUEFIN BIOMEDICINE, INC.
    Inventors: Tinglei Gu, Scott Michael Lonning, Jason G. Beaudet, Sean A. Beausoleil, Nels Eric Pederson, Daniel Mulhern
  • ANTI-TMEFF1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20200109194
    Abstract: Disclosed herein are transmembrane protein with EGF-like and two-follistatin-like domains 1 (TMEFF1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: March 22, 2018
    Publication date: April 9, 2020
    Applicant: Bluefin BioMedicine, Inc.
    Inventors: Isabel Milan Chu, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev, Jason G. Beaudet
  • ANTI-ILT3 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20200031926
    Abstract: Disclosed herein are anti-immunoglobulin-like transcript-3 (ILT3) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs.
    Type: Application
    Filed: February 9, 2018
    Publication date: January 30, 2020
    Applicant: Bluefin BioMedicine, Inc.
    Inventors: Jaime Darce, Scott Michael Lonning, Nels Eric Pederson, Klarisa Rikova, Aleksandr Tkachev
  • Anti-mucin 1 binding agents and uses thereof
    Patent number: 10208125
    Abstract: This disclosure provides anti-MUC1 binding agents (e.g., antibodies and chimeric antigen receptors) and methods of treatment, prophylaxis, detection, and diagnosis using the same.
    Type: Grant
    Filed: July 14, 2014
    Date of Patent: February 19, 2019
    Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education, Bluefin BioMedicine, Inc.
    Inventors: Robert E. Schoen, Olivera J. Finn, Shuji Sato, Wan Cheung Cheung, Roberto D. Polakiewicz